Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study
Open Access
- 1 May 1997
- journal article
- clinical trial
- Published by American Society of Hematology in Blood
- Vol. 89 (9), 3323-3329
- https://doi.org/10.1182/blood.v89.9.3323
Abstract
Compared with younger patients, elderly patients with acute myeloid leukemia (AML) respond poorly to conventional chemotherapy. To determine if thisKeywords
This publication has 33 references indexed in Scilit:
- P‐glycoprotein expression on acute myeloid leukaemia blast cells at diagnosis predicts response to chemotherapy and survivalBritish Journal of Haematology, 1994
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- Age‐related incidence and other epidemiological aspects of myelodysplastic syndromesBritish Journal of Haematology, 1992
- Cytogenetics and their prognostic value in de novo acute myeloid leukaemia: a report on 283 casesBritish Journal of Haematology, 1989
- Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemiaBritish Journal of Haematology, 1988
- PRINCIPAL RESULTS OF THE MEDICAL RESEARCH COUNCIL'S 8th ACUTE MYELOID LEUKAEMIA TRIALThe Lancet, 1986
- Myelodysplastic syndromes. A clinical and pathologic analysis of 109 casesCancer, 1985
- Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources.Journal of Histochemistry & Cytochemistry, 1977
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958